JP2002509889A - 膜型マトリックスメタロプロテイナーゼを阻害する方法 - Google Patents
膜型マトリックスメタロプロテイナーゼを阻害する方法Info
- Publication number
- JP2002509889A JP2002509889A JP2000540834A JP2000540834A JP2002509889A JP 2002509889 A JP2002509889 A JP 2002509889A JP 2000540834 A JP2000540834 A JP 2000540834A JP 2000540834 A JP2000540834 A JP 2000540834A JP 2002509889 A JP2002509889 A JP 2002509889A
- Authority
- JP
- Japan
- Prior art keywords
- cmt
- tetracycline
- mmp
- dimethylamino
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/052,222 | 1998-03-31 | ||
| US09/052,222 US6277061B1 (en) | 1998-03-31 | 1998-03-31 | Method of inhibiting membrane-type matrix metalloproteinase |
| PCT/US1999/006972 WO1999049871A1 (en) | 1998-03-31 | 1999-03-30 | Method of inhibiting membrane-type matrix metalloproteinase |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002509889A true JP2002509889A (ja) | 2002-04-02 |
| JP2002509889A5 JP2002509889A5 (cg-RX-API-DMAC7.html) | 2006-06-01 |
Family
ID=21976191
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000540834A Abandoned JP2002509889A (ja) | 1998-03-31 | 1999-03-30 | 膜型マトリックスメタロプロテイナーゼを阻害する方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US6277061B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1079837A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2002509889A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20010042322A (cg-RX-API-DMAC7.html) |
| AU (1) | AU748870B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2320260A1 (cg-RX-API-DMAC7.html) |
| NZ (1) | NZ506153A (cg-RX-API-DMAC7.html) |
| WO (1) | WO1999049871A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6506740B1 (en) * | 1998-11-18 | 2003-01-14 | Robert A. Ashley | 4-dedimethylaminotetracycline derivatives |
| EP1174129A1 (en) * | 2000-07-17 | 2002-01-23 | Zenner, Hans Peter, Prof. Dr. med. | Use of a matrix-metalloprotease inhibitor for the treatment of cancer |
| EP1408987B1 (en) | 2001-07-13 | 2013-04-10 | Paratek Pharmaceuticals, Inc. | Tetracycline compounds having target therapeutic activities |
| WO2003030819A2 (en) * | 2001-10-05 | 2003-04-17 | Tetragenex Pharmaceuticals, Inc. | Tetracycline derivatives and methods of use thereof |
| CN100391464C (zh) * | 2001-12-03 | 2008-06-04 | 诺瓦西股份有限公司 | 含活性维生素d化合物的药物组合物 |
| WO2003053447A1 (en) * | 2001-12-20 | 2003-07-03 | Hanauske-Abel Hartmut M | Treatment for averting or delaying premature delivery |
| EP2311797A1 (en) | 2002-01-08 | 2011-04-20 | Paratek Pharmaceuticals, Inc. | 4-dedimethylamino tetracycline compounds |
| JP2005526754A (ja) | 2002-03-08 | 2005-09-08 | パラテック ファーマシューティカルズ インコーポレイテッド | アミノメチル置換されたテトラサイクリン化合物 |
| EP1503981A4 (en) | 2002-03-21 | 2007-08-15 | Paratek Pharm Innc | SUBSTITUTED TETRACYCLINE COMPOUNDS |
| WO2003082011A1 (en) * | 2002-03-29 | 2003-10-09 | The Research Foundation Of State University Of New York | Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins |
| WO2004006850A2 (en) | 2002-07-12 | 2004-01-22 | Paratek Pharmaceuticals, Inc | 3, 10, AND 12a SUBSTITUTED TETRACYCLINE COMPOUNDS |
| US20040170621A1 (en) * | 2002-08-30 | 2004-09-02 | Roodman G. David | Method of resisting osteoclast formation |
| US20040138162A1 (en) * | 2002-08-30 | 2004-07-15 | Roodman G. David | Method of resisting osteoclast formation |
| JP4686189B2 (ja) | 2002-10-24 | 2011-05-18 | パラテック ファーマシューティカルズ インコーポレイテッド | Rnaを調節するための置換テトラサイクリン化合物の使用方法 |
| WO2004060346A2 (en) | 2002-12-30 | 2004-07-22 | Angiotech International Ag | Drug delivery from rapid gelling polymer composition |
| WO2005009943A2 (en) | 2003-07-09 | 2005-02-03 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
| JP4738333B2 (ja) | 2003-07-09 | 2011-08-03 | パラテック ファーマシューティカルズ インコーポレイテッド | 9−アミノメチルテトラサイクリン化合物のプロドラッグ |
| EP2332904A3 (en) * | 2004-01-15 | 2012-04-11 | Paratek Pharmaceuticals, Inc. | Derivatives of tetracycline compounds |
| JP2008518025A (ja) | 2004-10-25 | 2008-05-29 | パラテック ファーマシューティカルズ インコーポレイテッド | 4−アミノテトラサイクリンおよびその使用の方法 |
| WO2006047756A2 (en) | 2004-10-25 | 2006-05-04 | Paratek Pharmaceuticals, Inc. | Substituted tetracycline compounds |
| CA2616224A1 (en) * | 2005-07-21 | 2007-02-01 | Paratek Pharmaceuticals, Inc. | 10-substituted tetracyclines and methods of use thereof |
| US20070142337A1 (en) * | 2005-12-15 | 2007-06-21 | The Regents Of The University Of California | Treatment of inflammation and organ dysfunction |
| PL2120963T3 (pl) | 2006-12-21 | 2019-05-31 | Paratek Pharm Innc | Podstawione związki tetracyklinowe do leczenia zaburzeń zapalnych skóry |
| IL270446B2 (en) * | 2006-12-21 | 2023-10-01 | Paratek Pharm Innc | A tetracycline compound, a pharmaceutical preparation containing the tetracycline compound, and the tetracycline compound or the pharmaceutical preparation for the treatment of the tetracycline-responsive condition |
| EP2144870A2 (en) * | 2007-04-27 | 2010-01-20 | Paratek Pharmaceuticals, Inc. | Methods for synthesizing and purifying aminoalkyl tetracycline compounds |
| WO2009009042A1 (en) * | 2007-07-06 | 2009-01-15 | Paratek Pharmaceuticals, Inc. | Methods for synthesizing substituted tetracycline compounds |
| TWI585071B (zh) | 2008-05-19 | 2017-06-01 | 派洛泰克藥物股份有限公司 | 四環素化合物之甲苯磺酸鹽及同素異形體 |
| HUE026562T2 (hu) | 2008-08-08 | 2016-06-28 | Tetraphase Pharmaceuticals Inc | C7-fluor-helyettesített tetraciklin vegyületek |
| CN102459153A (zh) | 2009-05-08 | 2012-05-16 | 四相制药公司 | 四环素类化合物 |
| EP2470500B1 (en) | 2009-08-28 | 2017-10-04 | Tetraphase Pharmaceuticals, Inc. | Tetracycline compounds |
| WO2011123536A1 (en) | 2010-03-31 | 2011-10-06 | Tetraphase Pharmaceuticals, Inc. | Polycyclic tetracycline compounds |
| LT2707003T (lt) | 2011-05-12 | 2019-10-10 | Paratek Pharmaceuticals, Inc. | Kristalinės (4s,4as,5ar,12as)-4-dimetilamino-3,10,12,12a-tetrahidroksi-7-[(metoksi(metil)amino)-metil]-1,11-diokso-1,4,4a,5,5a,6,11,12a-oktahidro-naftacen-2-karboksirūgšties amido druskos ir jų panaudojimo būdai |
| TR201902057T4 (tr) | 2012-08-31 | 2019-03-21 | Tetraphase Pharmaceuticals Inc | Tetrasiklin bileşikleri. |
| MA46567A (fr) | 2016-10-19 | 2019-08-28 | Tetraphase Pharmaceuticals Inc | Formes cristallines de l'éravacycline |
| WO2020097450A1 (en) | 2018-11-09 | 2020-05-14 | Tetraphase Pharmaceuticals, Inc. | Polymorphic forms of a compound and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4704383A (en) * | 1983-12-29 | 1987-11-03 | The Research Foundation Of State University Of New York | Non-antibacterial tetracycline compositions possessing anti-collagenolytic properties and methods of preparing and using same |
| US4925833A (en) * | 1983-12-29 | 1990-05-15 | The Research Foundation Of State University Of New York | Use of tetracycline to enhance bone protein synthesis and/or treatment of osteoporosis |
| AU1411992A (en) | 1991-01-15 | 1992-08-27 | Robert A Bok | A composition containing a tetracycline and use for inhibiting angiogenesis |
| JPH06256280A (ja) * | 1992-11-17 | 1994-09-13 | Univ New York State | 糖尿病における過度のコラーゲン架橋結合を阻害する非抗菌性化学修飾テトラサイクリンを含むテトラサイクリン |
| US5668122A (en) * | 1993-07-28 | 1997-09-16 | Fife; Rose S. | Method to treat cancer with tetracyclines |
| GB9615976D0 (en) | 1996-07-30 | 1996-09-11 | Center For Clinical & Basic Re | The use of proteinase inhibitors for the prevention or reduction of bone resorption |
| US5789395A (en) * | 1996-08-30 | 1998-08-04 | The Research Foundation Of State University Of New York | Method of using tetracycline compounds for inhibition of endogenous nitric oxide production |
| US5837696A (en) | 1997-01-15 | 1998-11-17 | The Research Foundation Of State University Of New York | Method of inhibiting cancer growth |
-
1998
- 1998-03-31 US US09/052,222 patent/US6277061B1/en not_active Expired - Lifetime
-
1999
- 1999-03-30 EP EP99916213A patent/EP1079837A4/en not_active Withdrawn
- 1999-03-30 NZ NZ506153A patent/NZ506153A/en unknown
- 1999-03-30 WO PCT/US1999/006972 patent/WO1999049871A1/en not_active Ceased
- 1999-03-30 AU AU34576/99A patent/AU748870B2/en not_active Ceased
- 1999-03-30 JP JP2000540834A patent/JP2002509889A/ja not_active Abandoned
- 1999-03-30 CA CA002320260A patent/CA2320260A1/en not_active Abandoned
- 1999-03-30 KR KR1020007010871A patent/KR20010042322A/ko not_active Ceased
-
2001
- 2001-05-14 US US09/855,067 patent/US20020045603A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NZ506153A (en) | 2003-10-31 |
| AU3457699A (en) | 1999-10-18 |
| US6277061B1 (en) | 2001-08-21 |
| US20020045603A1 (en) | 2002-04-18 |
| WO1999049871A8 (en) | 1999-12-02 |
| CA2320260A1 (en) | 1999-10-07 |
| AU748870B2 (en) | 2002-06-13 |
| WO1999049871A1 (en) | 1999-10-07 |
| EP1079837A4 (en) | 2003-07-02 |
| EP1079837A1 (en) | 2001-03-07 |
| KR20010042322A (ko) | 2001-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU748870B2 (en) | Method of inhibiting membrane-type matrix metalloproteinase | |
| JP4428727B2 (ja) | 癌の成長を抑制する方法 | |
| Vartak et al. | Matrix metalloproteases: underutilized targets for drug delivery | |
| JP4339411B2 (ja) | 疎水性テトラサイクリンによるセリンプロテイナーゼ阻害活性 | |
| Johnson et al. | Matrix metalloproteinases | |
| ES2237945T3 (es) | Combinacion de bisfosfonato y tetraciclina. | |
| US7638127B2 (en) | Peptide conjugated anti-cancer prodrugs | |
| JP2676080B2 (ja) | 非抗バクテリア性テトラサイクリン組成物 | |
| DE69322659T2 (de) | Pharmazeutische zubereitung enthaltend eine beta-lactam antibiotikum abbauende verbindung, und deren verwendung | |
| US20090269405A1 (en) | Enzyme mediated delivery system | |
| Lee et al. | CMT-3, a non-antimicrobial tetracycline (TC), inhibits MT1-MMP activity: relevance to cancer | |
| EP1459738A1 (en) | Pharmaceutical composition having thrombolytic, anti-inflammatory and cytoprotective properties | |
| JP2002506881A (ja) | 新規マトリックスメタロプロテイナーゼ阻害剤および下方調節剤 | |
| US6429204B1 (en) | Method of inhibiting cancer growth | |
| US20070027064A1 (en) | Pharmaceutical compositions for inhibiting metal ion dependent enzymatic activity and methods for the use thereof | |
| JP4630661B2 (ja) | 線維症および瘢痕形成の治療におけるコンバターゼインヒビターの使用 | |
| EP0369035A1 (en) | Agent for treating pancreatitis or the like | |
| KR100274172B1 (ko) | 타입 iv 콜라게네이즈 활성을 억제하는 timp-2 유래 합성펩타이드 | |
| Rathna et al. | Recent Insights of Matrix Metalloproteinase Inhibitors in Therapeutic Applications | |
| US20020151481A1 (en) | MMP-2 propeptide for use as antiangiogenic or antitumor agent | |
| Naidu et al. | Lefty peptides, derived by MMP2 cleavage, act as a new class of gelatinase A inhibitor | |
| Riedlinger et al. | Metastatic melanoma and matrix metalloproteinases | |
| Acid | Correlation of Antiangiogenic and Antitumor Efficacy of | |
| MXPA99006554A (en) | Method of inhibiting cancer growth | |
| WILLIAMS-HERMAN et al. | metalloproteinases) and intracellular degradation involving lysosomal proteolysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060329 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20060329 |
|
| A762 | Written abandonment of application |
Free format text: JAPANESE INTERMEDIATE CODE: A762 Effective date: 20071228 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20071228 |